OpenURL Connection Search

Select item for more details and to access through your institution.

DOTA-NOC, A high affinity ligand of the somatostatin receptor subtypes 2, 3 and 5 for radiotherapy.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2001, v. 44, p. S697, doi. 10.1002/jlcr.25804401246
By:
- Schmitt, J. S.;
- Wild, D.;
- Ginj, M.;
- Reubi, J. C.;
- Waser, B.;
- de Jong, M.;
- Bernard, B. F.;
- Krenning, E. P.;
- Mäcke, H. R.
Publication type:
Article
Comparison of 99mTc octreotide-tetramine conjugates with in vitro and in vivo affinity for the somatostatin receptor.
Published in:
Journal of Labelled Compounds & Radiopharmaceuticals, 2001, v. 44, p. S576, doi. 10.1002/jlcr.25804401204
By:
- Nikolopoulou, A.;
- Maina, T.;
- Nock, B.;
- Tsipra, C.;
- Poppe, M.;
- Mäcke, H.;
- Chiotellis, E.
Publication type:
Article
Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges.
Published in:
Cancer & Metastasis Reviews, 2014, v. 33, n. 1, p. 353, doi. 10.1007/s10555-013-9465-1
By:
- Castaño, J.;
- Sundin, A.;
- Maecke, H.;
- Villabona, C.;
- Vazquez-Albertino, R.;
- Navarro, E.;
- Öberg, K.
Publication type:
Article
Glucagon-Like Peptide 1 Receptor (GLP-1 R) Imaging for the Preoperative Localization of Benign Insulinomas in 30 Patients.
Published in:
Neuroendocrinology, 2012, v. 96, p. 24
By:
- Christ, E.;
- Forrer, F.;
- Wild, D.;
- Clerici, T.;
- Braendle, M.;
- Maecke, H.;
- Ell, P. J.;
- Caplin, M.;
- Reubi, J. C.
Publication type:
Article
SOMscan: Towards a Ga-68-1abeled Pan-Somatostatin PET Imaging Probe Based on SOM230 (Pasireotide).
Published in:
Neuroendocrinology, 2012, v. 96, p. 3
By:
- Fani, M.;
- Braun, F.;
- Mann, A.;
- Kiewer, A.;
- Kaufmann, J.;
- Weber, W. A.;
- Bouterfa, H.;
- Schulz, S.;
- Maecke, H.
Publication type:
Article
μ-Oxoverbrückte, dimere Technetium- und Rheniumkomplexe mit funktionalisierten Aminophenolato-Liganden. Darstellung und Strukturen von [OTcL1OL1TcO] · H2O und [OReL1OL1ReO] (H2L1 = N,N′-Bis(2-hydroxybenzyl)-1,3-diamino-2-(4-nitrobenzyl)propan)
Published in:
Zeitschrift für Anorganische und Allgemeine Chemie, 1995, v. 621, n. 5, p. 854, doi. 10.1002/zaac.19956210525
By:
- Abram, U.;
- Abram, S.;
- Mäcke, H. R.;
- Koch, P.
Publication type:
Article
Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks.
Published in:
2015
By:
- Pfestroff, A.;
- Luster, M.;
- Jilg, C.;
- Olbert, P.;
- Ohlmann, C.;
- Lassmann, M.;
- Maecke, H.;
- Ezziddin, S.;
- Bodei, L.
Publication type:
Editorial
Somatostatin-based radiopeptide therapy with [Lu-DOTA]-TOC versus [Y-DOTA]-TOC in neuroendocrine tumours.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2014, v. 41, n. 2, p. 214, doi. 10.1007/s00259-013-2559-8
By:
- Romer, A.;
- Seiler, D.;
- Marincek, N.;
- Brunner, P.;
- Koller, M.;
- Ng, Q.;
- Maecke, H.;
- Müller-Brand, J.;
- Rochlitz, C.;
- Briel, M.;
- Schindler, C.;
- Walter, M.
Publication type:
Article
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 7, p. 1335, doi. 10.1007/s00259-010-1385-5
By:
- Cordier, D.;
- Forrer, F.;
- Bruchertseifer, F.;
- Morgenstern, A.;
- Apostolidis, C.;
- Good, S.;
- Müller-Brand, J.;
- Mäcke, H.;
- Reubi, J.;
- Merlo, A.
Publication type:
Article
Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2007, v. 34, n. 7, p. 982, doi. 10.1007/s00259-006-0317-x
By:
- Antunes, P.;
- Ginj, M.;
- Zhang, H.;
- Waser, B.;
- Baum, R.;
- Reubi, J.;
- Maecke, H.
Publication type:
Article
99mTc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years’ experience.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 10, p. 1123, doi. 10.1007/s00259-006-0113-7
By:
- Hubalewska-Dydejczyk, A.;
- Fröss-Baron, K.;
- Mikołajczak, R.;
- Maecke, H. R.;
- Huszno, B.;
- Pach, D.;
- Sowa-Staszczak, A.;
- Janota, B.;
- Szybiński, P.;
- Kulig, J.
Publication type:
Article
Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours.
Published in:
2005
By:
- Forrer, F.;
- Mueller-Brand, J.;
- Maecke, H.
Publication type:
Letter
A comparison of 111In-DOTATOC and 111In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 9, p. 1257, doi. 10.1007/s00259-004-1553-6
By:
- Forrer, F.;
- Uusijärvi, H.;
- Waldherr, C.;
- Cremonesi, M.;
- Bernhardt, P.;
- Mueller-Brand, J.;
- Maecke, H. A.
Publication type:
Article
68Ga-labelled DOTA-derivatised peptide ligands.
Published in:
European Journal of Nuclear Medicine & Molecular Imaging, 2004, v. 31, n. 8, p. 1097, doi. 10.1007/s00259-004-1486-0
By:
- Meyer, G.-J.;
- Mäcke, H.;
- Schuhmacher, J.;
- Knapp, W. H.;
- Hofmann, M.
Publication type:
Article
Somatostatin Analogues for Somatostatin-Receptor-Mediated Radiotherapy of Cancer.
Published in:
Digestion, 1996, v. 57, n. S1, p. 17, doi. 10.1159/000201387
By:
- Stolz, B.;
- Smith-Jones, P.;
- Albert, R.;
- Tolcsvai, L.;
- Briner, U.;
- Ruser, G.;
- Mäcke, H.;
- Weckbecker, G.;
- Brims, C.
Publication type:
Article
Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy.
Published in:
Chemistry - A European Journal, 1999, v. 5, n. 7, p. 1974, doi. 10.1002/(SICI)1521-3765(19990702)5:7<1974::AID-CHEM1974>3.0.CO;2-X
By:
- Heppeler, A.;
- Froidevaux, S.;
- Mäcke, H. R.;
- Jermann, E.;
- Béhé, M.;
- Powell, P.;
- Hennig, M.
Publication type:
Article
Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.
Published in:
Alimentary Pharmacology & Therapeutics, 2001, v. 15, n. 11, p. 1745, doi. 10.1046/j.1365-2036.2001.01103.x
By:
- Degen, L.;
- Matzinger, D.;
- Merz, M.;
- Appel‐Dingemanse, S.;
- Osborne, S.;
- Lüchinger, S.;
- Bertold, R.;
- Maecke, H.;
- Beglinger, C.
Publication type:
Article
Gd-DOTA as a gastrointestinal contrast agent for gastric emptying measurements with MRI.
Published in:
Magnetic Resonance in Medicine, 1994, v. 31, n. 4, p. 388, doi. 10.1002/mrm.1910310407
By:
- Schwizer, W.;
- Fraser, R.;
- Maecke, H.;
- Siebold, K.;
- Funck, R.;
- Fried, M.
Publication type:
Article
Successful Targeted Radiotherapy with Y-DOTATOC in a Patient with Merkel Cell Carcinoma.
Published in:
Oncology, 2004, v. 66, n. 2, p. 160, doi. 10.1159/000077443
By:
- Meier, G.;
- Waldherr, C.;
- Herrmann, R.;
- Maecke, H.;
- Mueller-Brand, J.;
- Pless, M.
Publication type:
Article
Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour.
Published in:
British Journal of Cancer, 2005, v. 93, n. 10, p. 1144, doi. 10.1038/sj.bjc.6602845
By:
- Kölby, L.;
- Bernhardt, P.;
- Johanson, V.;
- Schmitt, A.;
- Ahlman, H.;
- Forssell-Aronsson, E.;
- Mäcke, H.;
- Nilsson, O.
Publication type:
Article
Über Reaktionen Oxygenierter Kobalt (II)-Komplexe. X. 1,4,7,10-Tetraazadecan-kobalt (II) und 4, 7-dimethyl-1,4,7,10-tetraazadecan-kobalt (II) als sauerstoffträger.
Published in:
Helvetica Chimica Acta, 1979, v. 62, n. 6, p. 1804, doi. 10.1002/hlca.19790620612
By:
- Mäcke, H.;
- Zehnder, M.;
- Thewalt, U.;
- Fallab, S.
Publication type:
Article

Found: 21

DOTA-NOC, A high affinity ligand of the somatostatin receptor subtypes 2, 3 and 5 for radiotherapy.

Comparison of <sup>99m</sup>Tc octreotide-tetramine conjugates with in vitro and in vivo affinity for the somatostatin receptor.

Gastrointestinal neuroendocrine tumors (NETs): new diagnostic and therapeutic challenges.

Glucagon-Like Peptide 1 Receptor (GLP-1 R) Imaging for the Preoperative Localization of Benign Insulinomas in 30 Patients.

SOMscan: Towards a Ga-68-1abeled Pan-Somatostatin PET Imaging Probe Based on SOM230 (Pasireotide).

Current status and future perspectives of PSMA-targeted therapy in Europe: opportunity knocks.

Somatostatin-based radiopeptide therapy with [Lu-DOTA]-TOC versus [Y-DOTA]-TOC in neuroendocrine tumours.

Targeted alpha-radionuclide therapy of functionally critically located gliomas with <sup>213</sup>Bi-DOTA-[Thi<sup>8</sup>,Met(O<sub>2</sub>)<sup>11</sup>]-substance P: a pilot trial.

Are radiogallium-labelled DOTA-conjugated somatostatin analogues superior to those labelled with other radiometals?

<sup>99m</sup>Tc-EDDA/HYNIC-octreotate scintigraphy, an efficient method for the detection and staging of carcinoid tumours: results of 3 years’ experience.

Pre-therapeutic dosimetry with radiolabelled somatostatin analogues in patients with advanced neuroendocrine tumours.

A comparison of <sup>111</sup>In-DOTATOC and <sup>111</sup>In-DOTATATE: biodistribution and dosimetry in the same patients with metastatic neuroendocrine tumours.

<sup>68</sup>Ga-labelled DOTA-derivatised peptide ligands.

Somatostatin Analogues for Somatostatin-Receptor-Mediated Radiotherapy of Cancer.

Radiometal-Labelled Macrocyclic Chelator-Derivatised Somatostatin Analogue with Superb Tumour-Targeting Properties and Potential for Receptor-Mediated Internal Radiotherapy.

Tegaserod, a 5-HT<sub>4</sub> receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects.

Gd-DOTA as a gastrointestinal contrast agent for gastric emptying measurements with MRI.

Successful Targeted Radiotherapy with Y-DOTATOC in a Patient with Merkel Cell Carcinoma.

Successful receptor-mediated radiation therapy of xenografted human midgut carcinoid tumour.

Über Reaktionen Oxygenierter Kobalt (II)-Komplexe. X. 1,4,7,10-Tetraazadecan-kobalt (II) und 4, 7-dimethyl-1,4,7,10-tetraazadecan-kobalt (II) als sauerstoffträger.